Latest News from: Alzheimer's Center at Temple University Lewis Katz School of Medicine

Filters close
Released: 24-Jun-2024 12:05 PM EDT
Low ABCA7 Protein May Indicate Alzheimer's Risk
Alzheimer's Center at Temple University Lewis Katz School of Medicine

People aged 60-80 with low levels of the protein ABCA7 in the brain appear more likely to develop Alzheimer’s disease, according to a new study published in the Journal of Neuropathology & Experimental Neurology.

Released: 29-Apr-2024 6:05 PM EDT
Early Alzheimer’s Detection with Artificial Intelligence
Alzheimer's Center at Temple University Lewis Katz School of Medicine

“AI-driven neuroimaging techniques have the potential to improve prediction models for Alzheimer’s progression and facilitate personalized treatment strategies,” says Domenico Praticò, MD, the Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple (ACT), at the Lewis Katz School of Medicine at Temple University (LKSOM).

Released: 12-Apr-2024 8:05 AM EDT
Young-Onset Dementia Tied to New Risk Factors
Alzheimer's Center at Temple University Lewis Katz School of Medicine

“Are the risk factors for early onset Alzheimer’s the same as late onset?” asks Domenico Praticò, MD, the Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple (ACT), at the Lewis Katz School of Medicine at Temple University (LKSOM)

Released: 14-Feb-2024 4:05 AM EST
Can Olive Oil Reverse Genetic Predisposition for Alzheimer’s?
Alzheimer's Center at Temple University Lewis Katz School of Medicine

Clinical studies suggest the Mediterranean diet, and one of its main components, extra virgin olive oil (EVOO), improves cognitive function and slows Alzheimer's disease (AD) progression. Researchers will now investigate whether this is true even for people with a family history of AD and signs of genetic predisposition caused by dysfunction in the APOE gene.

Released: 1-Nov-2023 9:05 AM EDT
How reliable is a home test in predicting Alzheimer's disease?
Alzheimer's Center at Temple University Lewis Katz School of Medicine

The test alone will not provide enough information to reach a diagnosis of memory problems/cognitive decline. Only a trained physician can do it.

Released: 21-Sep-2023 9:30 AM EDT
World Alzheimer’s Month 2023: Shining a Light on Alzheimer's – Domenico Praticò
Alzheimer's Center at Temple University Lewis Katz School of Medicine

Since 2012, September has been celebrated as World Alzheimer’s Month. Back then, and only eleven years ago, an average of 2 out of 3 people had little understanding of Alzheimer's disease and associated dementias.

Released: 19-Sep-2023 9:05 AM EDT
Brain Injury Prevention in Contact Sports is Essential, Expert Says
Alzheimer's Center at Temple University Lewis Katz School of Medicine

“There is abundant evidence of a link between contact sports, such as football, and dementia later in life,” comments Domenico Pratico, M.D., Director of the Alzheimer’s Center at Temple University (ACT).

Released: 19-Sep-2023 8:05 AM EDT
Cholesterol and Inflammation Demonstrate Alzheimer’s Link
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A recent study shows that a protein called ABCA7 plays a functional role as a potential biological link between cholesterol and inflammation in Alzheimer’s disease. The new work was published online August 25 in the journal Cells.

Released: 25-Jul-2023 12:50 PM EDT
AI Study Uncovers Olive Oil's Potential in Combating Alzheimer's Disease
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A recent study has used Artificial Intelligence (AI) to reveal the remarkable potential of extra virgin olive oil (EVOO) in the fight against Alzheimer's disease (AD). Researchers combined AI technology, chemistry, and omics research to identify specific bioactive compounds in EVOO that show promising effects in treating and preventing AD.

Released: 13-Jun-2023 11:40 AM EDT
Potential Improvement of Learning and Memory in Down Syndrome
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A new approach could enhance memory and learning in individuals with Down syndrome by stabilizing a key component in the body's protein sorting system called the retromer complex.

Released: 29-May-2023 5:05 PM EDT
The Search For Alzheimer's Disease Biomarkers
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A biomarker is a characteristic that can be measured and evaluated as an indicator of normal biological processes, pathogenetic processes, or pharmacologic responses to a therapeutic intervention. In the context of Alzheimer’s disease (AD), an AD biomarker indicates the presence or progression of the disease that may be altered by drug treatment, thereby demonstrating that it is hitting its target. Today, all clinical trials for Alzheimer’s disease utilize biomarkers of some form to assess whether the drug is actually affecting the disease in the brain.

Released: 29-May-2023 4:50 PM EDT
Katz School of Medicine opens Alzheimer’s Center
Alzheimer's Center at Temple University Lewis Katz School of Medicine

The Lewis Katz School of Medicine created the Alzheimer’s Center at Temple from funds donated by Board of Trustees member Phil Richards earlier this month. Richards’s gift created the center and established the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research.

Released: 29-May-2023 4:05 PM EDT
Can Music Help Patients with Alzheimer's Disease?
Alzheimer's Center at Temple University Lewis Katz School of Medicine

Did you know that music might be able to connect you with your family members affected by Alzheimer's disease (AD) in a way that words cannot? Many studies have shown that music can evoke a response or a memory in people with Alzheimer's Disease.

Released: 29-May-2023 3:30 PM EDT
Medications to avoid for a patient with Alzheimer’s disease
Alzheimer's Center at Temple University Lewis Katz School of Medicine

The risk of side effects can rise if drugs are taken for conditions other than Alzheimer's disease (AD) treatment. Some sedatives and antidepressants can deteriorate cognitive function, make people drowsy and confused, and worsen cognitive impairment, which increases the risk of falls.



close
0.12291